Emivirine
Emivirine
Emivirine (pronounced as em-ee-vir-een) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that is primarily used in the treatment of HIV (Human Immunodeficiency Virus). It is an experimental drug and is not yet approved for general use.
Etymology
The term 'Emivirine' is derived from the words 'immune' and 'virine', which refer to the drug's function of inhibiting the replication of the HIV virus in the immune system.
Usage
Emivirine is used in combination with other antiretroviral drugs to treat HIV. It works by inhibiting the action of reverse transcriptase, an enzyme that the HIV virus needs to replicate itself. By blocking this enzyme, Emivirine prevents the virus from multiplying, thereby slowing the progression of the disease.
Related Terms
- Non-nucleoside reverse transcriptase inhibitors (NNRTIs): A class of antiretroviral drugs that includes Emivirine. Other drugs in this class include Efavirenz, Nevirapine, and Delavirdine.
- Reverse transcriptase: An enzyme that is crucial for the replication of the HIV virus. Inhibitors of this enzyme, such as Emivirine, are used to treat HIV.
- Antiretroviral therapy (ART): The treatment of HIV using a combination of antiretroviral drugs. Emivirine may be used as part of an ART regimen.
See Also
External links
- Medical encyclopedia article on Emivirine
- Wikipedia's article - Emivirine
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski